Cargando…

Hip arthritis in the TNF-Blockade era: an unresolved issue?

Detalles Bibliográficos
Autores principales:	Scott, C, Wouters, C, Moens, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334114/ http://dx.doi.org/10.1186/1546-0096-6-S1-P53

Ejemplares similares

TNF-alpha blockade by nonviral gene therapy in collagen-induced arthritis
por: Boissier, MC, et al.
Publicado: (2003)

A phenotypic shift after initiation of IL-1 receptor blockade in a boy with systemic juvenile arthritis
por: Scott, C, et al.
Publicado: (2008)

Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
por: Espada, G, et al.
Publicado: (2011)

Selective blockade of TGFbeta in the mice model of collagen-induced arthritis
por: Gonzalo, Elena, et al.
Publicado: (2011)

Efficacy and safety of anti-TNF agents in patients with enthesitis related arthritis
por: Tynjälä, P, et al.
Publicado: (2008)

Choosing the right treatment for patients with a severe course of chronic non-bacterial osteomyelitis (CNO) - pamidronate or TNF-α blockade?
por: Morbach, H, et al.
Publicado: (2015)

TNF inhibitors in the treatment of uveitis in the course of juvenile idiopathic arthritis
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2014)

Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
por: Rivarola, C, et al.
Publicado: (2008)

Adverse events during anti-TNF therapy in 269 patients with juvenile idiopathic arthritis
por: Tarkiainen, M, et al.
Publicado: (2008)

Preterm birth, an unresolved issue
por: Belizán, Jose M, et al.
Publicado: (2013)

Unresolved basic issues in hepatology
por: Weiskirchen, Ralf, et al.
Publicado: (2021)

Clinical and functional effectiveness of anti-TNF therapy in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalia, et al.
Publicado: (2011)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
por: Pontikaki, I, et al.
Publicado: (2008)

PReS-FINAL-2314: Anti-TNF alpha therapy for refractory childhood takayasu arthritis
por: Koren, B, et al.
Publicado: (2013)

TRAF1/C5 locus is associated with response to anti-TNF in rheumatoid arthritis
por: Canhão, Helena, et al.
Publicado: (2012)

Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF alpha monoclonal antibodies
por: Moshous, D, et al.
Publicado: (2011)

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
por: Joos, R, et al.
Publicado: (2011)

Aldosterone and the Heart: Still an Unresolved Issue?
por: Catena, Cristiana, et al.
Publicado: (2014)

COVID-19: Some unresolved issues
por: Gómez-Pavón, Javier, et al.
Publicado: (2022)

Effectiveness of tnf inhibitors therapy in children with juvenile idiopathic arthritis aged 2 to 5 years
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2014)

PReS-FINAL-2020: Cell type specific transcriptome analysis in patients with enthesitis related arthritis category of juvenile idiopathic arthritis (JIA-ERA)
por: Aggarwal, A, et al.
Publicado: (2013)

Synovial fibroblast hyperplasia correlates with rheumatoid arthritis duration and activity and is partially reversed by anti-TNF therapy
por: Izquierdo, E, et al.
Publicado: (2010)

PReS-FINAL-2044: TNF-alpha inhibitors in treatment of children with systemic form of juvenile idiopathic arthritis
por: Zholobova, ES, et al.
Publicado: (2013)

Juvenile idiopathic arthritis with dry synovitis: clinical and imaging aspects in a cohort of 6 patients
por: De Somer, L, et al.
Publicado: (2011)

PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis
por: Woerner, A, et al.
Publicado: (2013)

Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)
por: Salmaso, A, et al.
Publicado: (2008)

PReS-FINAL-2026: Glucose and lipid metabolism in children with juvenile idiopathic arthritis treated with anti-TNF-alpha
por: Christensen, AE, et al.
Publicado: (2013)

PReS-FINAL-2064: Effect of Goloimumab a new anti-TNF, in patients with the diagnosis of juvenile idiopathic arthritis
por: Kienast, A, et al.
Publicado: (2013)

TRPA1 and Cold Transduction: An Unresolved Issue?
por: Caspani, Ombretta, et al.
Publicado: (2009)

Open questions: some unresolved issues in biodiversity
por: Magurran, Anne E
Publicado: (2013)

Unresolved issues in pre-meiotic anther development
por: Kelliher, Timothy, et al.
Publicado: (2014)

Hypoplastic Left Heart Syndrome – Unresolved Issues
por: Arnold, Raoul Roman, et al.
Publicado: (2014)

Structure of Negative Symptoms in Schizophrenia: An Unresolved Issue
por: Russo, Manuela, et al.
Publicado: (2021)

Investigation of the role of the p38 MAPK α and δ isoforms in nonresponse to tumour necrosis factor blockade in the synovium of rheumatoid arthritis patients
por: Coulthard, LR, et al.
Publicado: (2007)

Safety and efficacy of biological therapy with TNF-inhibitors and non TNF-inhibitors in a cohort of young adults affected by juvenile idiopathic arthritis (JIA): data from a single centre experience
por: Lorenzo, Ceri, et al.
Publicado: (2011)

Unravelling the phenotype of cardiovascular inflammation with magnetic resonance imaging: detecting the change with anti-TNF treatment in patients with rheumatoid arthritis
por: Puntmann, Valentina O, et al.
Publicado: (2011)

Combined depletion of interleukin-1 and interleukin-6 does not exceed single depletion of interleukin -1 in TNF-mediated arthritis
por: Hayer, Silvia, et al.
Publicado: (2012)

Switching from a first to a second tumour necrosis factor (TNF) alpha antagonist in patients with juvenile idiopathic arthritis
por: Schmeling, H, et al.
Publicado: (2008)

Tumor necrosis factor polymorphisms in psoriatic arthritis: association with the promoter polymorphism TNF-857 independent of the PSORS1 risk allele
por: Reich, K, et al.
Publicado: (2007)

Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age
por: Roca, Clara Giménez, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7tbs6aksvqg5ka3d83ssugvk5n